This manuscript shows that MYC expression drives platinum resistance in vitro and in vivo and identifies the dual PI3K – HDAC inhibitor fimepinostat as an agent that both reduces MYC expression and kills platinum resistant SCLC cells. The gene discussed is MYC; the disease is small cell lung carcinoma.